"Novato Community Hospital operates a 24-hour emergency department and offers services including inpatient and outpatient surgery, a critical care unit, imaging services, laboratory services, physical therapy services and a sports fitness center.The Joint Commission recognizes this hospital as a Primary Stroke Center for their exceptional ability to provide high-quality stroke care."

During the past decade, Sutter Cancer Research Consortium conducted 59 clinical trials. In the 10-year time frame, 59 clinical trials started and 79 clinical trials were completed, i.e. on average, 133.9% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 50 clinical trials were completed. i.e. 1000% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sutter Cancer Research Consortium" #1 sponsor was "National Cancer Institute (NCI)" with 67 trials, followed by "SWOG Cancer Research Network" with 33 trials sponsored, "Alliance for Clinical Trials in Oncology" with 10 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 8 trials sponsored and "GOG Foundation" with 8 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sutter Cancer Research Consortium" #1 collaborator was "National Cancer Institute (NCI)" with 61 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "SWOG Cancer Research Network" with 8 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator and "Cancer and Leukemia Group B" with 6 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Sutter Cancer Research Consortium" are "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Recurrent Breast Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Breast Cancer" (7 trials) and "Invasive Breast Carcinoma" (6 trials). Many other conditions were trialed in "Sutter Cancer Research Consortium" in a lesser frequency.

Most popular intervention types in "Sutter Cancer Research Consortium" are "Drug" (104 trials), "Other" (83 trials), "Biological" (58 trials), "Procedure" (24 trials) and "Radiation" (18 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (59 trials), "Quality-of-Life Assessment" (26 trials), "Bevacizumab" (20 trials), "Carboplatin" (13 trials) and "Paclitaxel" (13 trials). Other intervention names were less common.

The vast majority of trials in "Sutter Cancer Research Consortium" are 96 trials for "All" genders, 26 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Sutter Cancer Research Consortium". undefined are not yet recruiting, 11 are recruiting, 65 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 41 completed trials in Sutter Cancer Research Consortium, 2 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Sutter Cancer Research Consortium, 2 "Phase 1" clinical trials were conducted, 59 "Phase 2" clinical trials and 74 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".